[PDF][PDF] Final results from a multicenter, international, pivotal study of romidepsin in refractory cutaneous T-cell lymphoma
SJ Whittaker, MF Demierre, EJ Kim, AH Rook… - J Clin …, 2010 - researchtopractice.com
SJ Whittaker, MF Demierre, EJ Kim, AH Rook, A Lerner, M Duvic, J Scarisbrick, S Reddy…
J Clin Oncol, 2010•researchtopractice.comFinal Results from a Multicenter, International, Pivotal Study of Romidepsin in Refractory
Cutaneous T-Cell Lymphoma Page 1 Final Results from a Multicenter, International, Pivotal
Study of Romidepsin in Refractory Cutaneous T-Cell Lymphoma Whittaker SJ et al. J Clin Oncol
2010;28(29):4485-91. Page 2 Introduction > Primary cutaneous T-cell lymphoma (CTCL) is a
rare class of non-Hodgkin’s lymphoma that originates in the skin. > Single-agent romidepsin
induces apoptotic events in cancer cells by inhibiting histone deactylase (HDAC) enzymes. > A …
Cutaneous T-Cell Lymphoma Page 1 Final Results from a Multicenter, International, Pivotal
Study of Romidepsin in Refractory Cutaneous T-Cell Lymphoma Whittaker SJ et al. J Clin Oncol
2010;28(29):4485-91. Page 2 Introduction > Primary cutaneous T-cell lymphoma (CTCL) is a
rare class of non-Hodgkin’s lymphoma that originates in the skin. > Single-agent romidepsin
induces apoptotic events in cancer cells by inhibiting histone deactylase (HDAC) enzymes. > A …
> Primary cutaneous T-cell lymphoma (CTCL) is a rare class of non-Hodgkin’s lymphoma that originates in the skin.
researchtopractice.com